|
Additional information - this mdr is being submitted to include the below: h6: investigation results under type of investigation, investigation findings, investigation conclusions h11: investigation summary the information in this complaint (b)(4) has been evaluated.The batch 6008621 in question was manufactured at the reynosa site.The reference samples for the lot 6008621 have already been previously tested for visual inspection and tested for flow in the complaint (b)(4) on 20/jun/2025.All test results were found within specifications as per the test report complaint (b)(4) test report.Pdf attached in this record.Complaint investigations.Photo/sample was not provided.In order to test the product, the reference samples from the lot have been requested.Test results: visual test according to work instruction (wi) version 3.0 on reference samples, 10/10 samples passed the test.Functional air flow test according to wi version 2.0 on reference samples, 10/10 samples passed the test.Device history record (dhr) review: the lot 6008621 was manufactured according to the wi version 19, in the machine multivac 14, on 04/aug/2024, with a total of (b)(4) units.Glue-tubing lot: the lot 4g06294 was manufactured according to the wi version 15, in the machine lc01, on 01/aug/2024, with a total of (b)(4) unit.Review of the dhr showed that all relevant tests required during the related processes had been fulfilled and met the requirements.No deviation were identified related to the malfunction reported, no maintenance events were recorded.Trending: a query was run in database on 27/jun/2025 against malfunction code idd-pmc03.02 occlusion in the tubing and/or tubing connectors (e.G., occlusion alarm from the infusion pump may have sounded) and lot 6008621 and one other complaints have been registered in database for the same lot and malfunction code.Conclusion summary of the related event: as a result of the following: on the investigation on reference samples, no issue were found related to occlusion, harm no reportable, no defect on tests, no non-conformance (nc) raised during production, no more complaint was received on the lot in question and malfunction, no further action are required, therefore, this issue will be monitored through the post market surveillance activities.
|